Navigation Links
Rosetta Genomics Reports First Quarter 2008 Financial Results



Short-term bank loan, current maturities

of capital lease and of long-term loan $ 168 $ 247

Trade payables 797 516

Other accounts payable and accruals 1,099 1,102

Total current liabilities 2,064 1,865


Long-term bank loan and capital lease 50 16

Deferred revenue 228 228

Accrued severance pay 366 324

Total Long-term Liabilities 644 568



Share capital: 27 27

Additional paid-in capital 59,201 58,984

Other comprehensive income 28 86

Deficit accumulated during the

development stage (39,370) (35,492)

Total shareholders' equity 19,886 23,605

Total liabilities and shareholders'

equity $ 22,594 $ 26,038


(A development stage company)


U.S. dollars in thousands (except share and per share data)

Three months

Year ended December 31, ended March 31,

2007 2006 2008 2007


Operating expenses:

Research an

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
10. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
11. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer
Post Your Comments:
(Date:10/9/2015)... and ROCKVILLE, Md. , Oct. ... privately-held biotechnology company developing next generation vaccines based ... has entered into an exclusive worldwide licensing agreement ... the treatment or prevention of any and all ... agreement, Immunomic Therapeutics will receive an upfront payment ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... us. However, the current methods of separating those cells from their surroundings for ... damaging to the cells. , To address this, Ann Arbor-based startup Akadeum ...
(Date:10/8/2015)... 2015   Intrexon Corporation (NYSE: XON ... appointment of Joseph L. Vaillancourt as Senior ... Nimrodi who continues in his role as Head ... to generate sustainable, biologically based solutions to environmental problems. ... held a variety of key roles including, Vice President ...
(Date:10/8/2015)... Va. , Oct. 8, 2015  ATCC, the ... today that it has been selected by The Michael ... vital cell lines to academic, pharmaceutical, and biotechnology organizations ... the United States , and ... --> the United States , and ...
Breaking Biology Technology:
... Preventative Testing , , CINCINNATI, June 23 ... nation,s leading provider of physician office-based patient-education programs, reports ... programs, 16.9 percent more patients had PSA tests (prostate ... (colon cancer screening) compared to patients in practices without ...
... ... MasterControl Inc., a global provider of GxP process and document ... world leading provider of high performance electronic regulatory submission solutions for ... the Drug Information Association (DIA) 45th Annual Meeting. GxP2eCTD is ...
... June 23 SyntheMed, Inc. (OTC Bulletin Board: SYMD), ... of anti-adhesion products, announced today that the company was ... Innovation Award in pediatrics. The company is ... Sullivan medical device analysts in recognition of the development ...
Cached Biology Technology:
(Date:9/10/2015)... 2015 Report Details Emerging ... Opportunities and Revenue Prospects to Help You Stay ... especially new drug classes? Get the latest technological ... exclusive market data and industry knowledge, benefitting your ... opportunities and sales predictions. Visiongain,s new study ...
(Date:9/8/2015)... --  TREW Marketing and today ... for Engineers TM : Content and Online Marketing . ... about engineers, preferences for online content marketing and channels ... and trust, and where they look for that content ... with how to best implement online and content marketing ...
(Date:9/1/2015)... MOUNTAIN VIEW, Calif. , Sept. 1, 2015 ... interaction with travelers during airport passenger screening. This ... which the passenger screening process will become unintrusive. ... and pre-clearance based on voluntary background investigations will ... analysis from Frost & Sullivan, Global Airport ...
Breaking Biology News(10 mins):
... MEDFORD/SOMERVILLE, Mass. Maria Flytzani-Stephanopoulos of Tufts University,s ... AAAS Fellow for distinguished contributions to the field ... reactions on nanoscale metal oxides in fuel conversion ... is an honor bestowed upon AAS members by ...
... Eight Arizona State University faculty members are among ... for the Advancement of Science (AAAS), a prestigious international ... society. Brad Allenby, Richard Creath, James Elser, Patricia ... Spence will be recognized Feb. 14 at the Fellows ...
... experiment, researchers have provided some clues to one of ... together to form the basis of life. ... JBC , demonstrated how ancient RNA joined together to ... precursor to DNA, normally expands one nucleic base at ...
Cached Biology News:
Trop-2 Purified Anti-Human clone 162-46, Isotype Mouse IgG 1 , 100 µg Consult technical datasheet for details....
... Adapted to Sf-900 II ... isolated from Spodoptera frugiperda ... cells (1). The Sf21 ... serum-free suspension culture in ...
MAGP-2 (C-19)...
TGF-beta 2 MAb (Clone 8607)...
Biology Products: